nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—CYP2A6—Prednisolone—ankylosing spondylitis	0.318	0.629	CbGbCtD
Ezogabine—CYP2A6—Dexamethasone—ankylosing spondylitis	0.187	0.371	CbGbCtD
Ezogabine—Psychiatric symptom—Prednisone—ankylosing spondylitis	0.0369	0.0746	CcSEcCtD
Ezogabine—Raised liver function tests—Methotrexate—ankylosing spondylitis	0.00771	0.0156	CcSEcCtD
Ezogabine—Encephalopathy—Methotrexate—ankylosing spondylitis	0.00554	0.0112	CcSEcCtD
Ezogabine—Aphasia—Methotrexate—ankylosing spondylitis	0.00549	0.0111	CcSEcCtD
Ezogabine—Memory impairment—Prednisone—ankylosing spondylitis	0.00543	0.011	CcSEcCtD
Ezogabine—Euphoric mood—Prednisolone—ankylosing spondylitis	0.00504	0.0102	CcSEcCtD
Ezogabine—Euphoric mood—Triamcinolone—ankylosing spondylitis	0.00463	0.00935	CcSEcCtD
Ezogabine—Euphoric mood—Methylprednisolone—ankylosing spondylitis	0.00462	0.00933	CcSEcCtD
Ezogabine—Increased appetite—Prednisolone—ankylosing spondylitis	0.00453	0.00914	CcSEcCtD
Ezogabine—Osteoarthritis—Prednisolone—ankylosing spondylitis	0.00425	0.00859	CcSEcCtD
Ezogabine—Euphoric mood—Dexamethasone—ankylosing spondylitis	0.0042	0.00849	CcSEcCtD
Ezogabine—Euphoric mood—Betamethasone—ankylosing spondylitis	0.0042	0.00849	CcSEcCtD
Ezogabine—Increased appetite—Triamcinolone—ankylosing spondylitis	0.00416	0.00841	CcSEcCtD
Ezogabine—Increased appetite—Methylprednisolone—ankylosing spondylitis	0.00415	0.00839	CcSEcCtD
Ezogabine—Amnesia—Methylprednisolone—ankylosing spondylitis	0.00415	0.00839	CcSEcCtD
Ezogabine—Skin discolouration—Methotrexate—ankylosing spondylitis	0.00394	0.00796	CcSEcCtD
Ezogabine—Osteoarthritis—Triamcinolone—ankylosing spondylitis	0.00391	0.0079	CcSEcCtD
Ezogabine—Osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.0039	0.00788	CcSEcCtD
Ezogabine—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00381	0.0077	CcSEcCtD
Ezogabine—Increased appetite—Dexamethasone—ankylosing spondylitis	0.00378	0.00763	CcSEcCtD
Ezogabine—Increased appetite—Betamethasone—ankylosing spondylitis	0.00378	0.00763	CcSEcCtD
Ezogabine—Dysarthria—Methotrexate—ankylosing spondylitis	0.00376	0.0076	CcSEcCtD
Ezogabine—Euphoric mood—Prednisone—ankylosing spondylitis	0.00366	0.00739	CcSEcCtD
Ezogabine—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.00355	0.00717	CcSEcCtD
Ezogabine—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.00355	0.00717	CcSEcCtD
Ezogabine—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00347	0.007	CcSEcCtD
Ezogabine—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00347	0.007	CcSEcCtD
Ezogabine—Influenza—Triamcinolone—ankylosing spondylitis	0.00338	0.00683	CcSEcCtD
Ezogabine—Weight increased—Prednisolone—ankylosing spondylitis	0.00335	0.00676	CcSEcCtD
Ezogabine—Amnesia—Prednisone—ankylosing spondylitis	0.00329	0.00664	CcSEcCtD
Ezogabine—Increased appetite—Prednisone—ankylosing spondylitis	0.00329	0.00664	CcSEcCtD
Ezogabine—Coma—Methotrexate—ankylosing spondylitis	0.00325	0.00657	CcSEcCtD
Ezogabine—Osteoarthritis—Prednisone—ankylosing spondylitis	0.00309	0.00624	CcSEcCtD
Ezogabine—Weight increased—Triamcinolone—ankylosing spondylitis	0.00308	0.00621	CcSEcCtD
Ezogabine—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00307	0.0062	CcSEcCtD
Ezogabine—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00302	0.0061	CcSEcCtD
Ezogabine—Infestation—Methylprednisolone—ankylosing spondylitis	0.00301	0.00607	CcSEcCtD
Ezogabine—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00301	0.00607	CcSEcCtD
Ezogabine—Visual impairment—Prednisolone—ankylosing spondylitis	0.00284	0.00573	CcSEcCtD
Ezogabine—Weight increased—Dexamethasone—ankylosing spondylitis	0.00279	0.00564	CcSEcCtD
Ezogabine—Weight increased—Betamethasone—ankylosing spondylitis	0.00279	0.00564	CcSEcCtD
Ezogabine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00269	0.00543	CcSEcCtD
Ezogabine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.0026	0.00526	CcSEcCtD
Ezogabine—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00258	0.00522	CcSEcCtD
Ezogabine—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00252	0.0051	CcSEcCtD
Ezogabine—Neutropenia—Prednisone—ankylosing spondylitis	0.0025	0.00505	CcSEcCtD
Ezogabine—Hallucination—Dexamethasone—ankylosing spondylitis	0.00244	0.00493	CcSEcCtD
Ezogabine—Hallucination—Betamethasone—ankylosing spondylitis	0.00244	0.00493	CcSEcCtD
Ezogabine—Weight increased—Prednisone—ankylosing spondylitis	0.00243	0.00491	CcSEcCtD
Ezogabine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00241	0.00488	CcSEcCtD
Ezogabine—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00239	0.00482	CcSEcCtD
Ezogabine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00238	0.0048	CcSEcCtD
Ezogabine—Visual impairment—Betamethasone—ankylosing spondylitis	0.00237	0.00478	CcSEcCtD
Ezogabine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00237	0.00478	CcSEcCtD
Ezogabine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00237	0.00478	CcSEcCtD
Ezogabine—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00235	0.00475	CcSEcCtD
Ezogabine—Malaise—Prednisolone—ankylosing spondylitis	0.00231	0.00467	CcSEcCtD
Ezogabine—Vertigo—Prednisolone—ankylosing spondylitis	0.0023	0.00465	CcSEcCtD
Ezogabine—Syncope—Prednisolone—ankylosing spondylitis	0.0023	0.00464	CcSEcCtD
Ezogabine—Eye disorder—Betamethasone—ankylosing spondylitis	0.0023	0.00463	CcSEcCtD
Ezogabine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.0023	0.00463	CcSEcCtD
Ezogabine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00225	0.00455	CcSEcCtD
Ezogabine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00219	0.00441	CcSEcCtD
Ezogabine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00218	0.0044	CcSEcCtD
Ezogabine—Alopecia—Dexamethasone—ankylosing spondylitis	0.00217	0.00438	CcSEcCtD
Ezogabine—Alopecia—Betamethasone—ankylosing spondylitis	0.00217	0.00438	CcSEcCtD
Ezogabine—Discomfort—Prednisolone—ankylosing spondylitis	0.00216	0.00435	CcSEcCtD
Ezogabine—Hallucination—Prednisone—ankylosing spondylitis	0.00213	0.0043	CcSEcCtD
Ezogabine—Malaise—Triamcinolone—ankylosing spondylitis	0.00212	0.00429	CcSEcCtD
Ezogabine—Malaise—Methylprednisolone—ankylosing spondylitis	0.00212	0.00428	CcSEcCtD
Ezogabine—Vertigo—Triamcinolone—ankylosing spondylitis	0.00212	0.00427	CcSEcCtD
Ezogabine—Syncope—Triamcinolone—ankylosing spondylitis	0.00211	0.00427	CcSEcCtD
Ezogabine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00211	0.00427	CcSEcCtD
Ezogabine—Syncope—Methylprednisolone—ankylosing spondylitis	0.00211	0.00426	CcSEcCtD
Ezogabine—Dysuria—Methotrexate—ankylosing spondylitis	0.00209	0.00422	CcSEcCtD
Ezogabine—Neutropenia—Methotrexate—ankylosing spondylitis	0.00209	0.00422	CcSEcCtD
Ezogabine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00207	0.00418	CcSEcCtD
Ezogabine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00207	0.00417	CcSEcCtD
Ezogabine—Shock—Prednisolone—ankylosing spondylitis	0.00206	0.00415	CcSEcCtD
Ezogabine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00202	0.00408	CcSEcCtD
Ezogabine—Eye disorder—Prednisone—ankylosing spondylitis	0.002	0.00404	CcSEcCtD
Ezogabine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00199	0.00403	CcSEcCtD
Ezogabine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00199	0.00402	CcSEcCtD
Ezogabine—Infestation—Methotrexate—ankylosing spondylitis	0.00199	0.00402	CcSEcCtD
Ezogabine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00198	0.00401	CcSEcCtD
Ezogabine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00198	0.00401	CcSEcCtD
Ezogabine—Discomfort—Triamcinolone—ankylosing spondylitis	0.00198	0.004	CcSEcCtD
Ezogabine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00198	0.00399	CcSEcCtD
Ezogabine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00196	0.00396	CcSEcCtD
Ezogabine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00193	0.00391	CcSEcCtD
Ezogabine—Malaise—Dexamethasone—ankylosing spondylitis	0.00193	0.00389	CcSEcCtD
Ezogabine—Malaise—Betamethasone—ankylosing spondylitis	0.00193	0.00389	CcSEcCtD
Ezogabine—Vertigo—Betamethasone—ankylosing spondylitis	0.00192	0.00388	CcSEcCtD
Ezogabine—Vertigo—Dexamethasone—ankylosing spondylitis	0.00192	0.00388	CcSEcCtD
Ezogabine—Syncope—Betamethasone—ankylosing spondylitis	0.00192	0.00387	CcSEcCtD
Ezogabine—Syncope—Dexamethasone—ankylosing spondylitis	0.00192	0.00387	CcSEcCtD
Ezogabine—Infection—Triamcinolone—ankylosing spondylitis	0.00191	0.00386	CcSEcCtD
Ezogabine—Infection—Methylprednisolone—ankylosing spondylitis	0.00191	0.00385	CcSEcCtD
Ezogabine—Haematuria—Methotrexate—ankylosing spondylitis	0.0019	0.00383	CcSEcCtD
Ezogabine—Shock—Triamcinolone—ankylosing spondylitis	0.00189	0.00382	CcSEcCtD
Ezogabine—Alopecia—Prednisone—ankylosing spondylitis	0.00189	0.00382	CcSEcCtD
Ezogabine—Shock—Methylprednisolone—ankylosing spondylitis	0.00189	0.00381	CcSEcCtD
Ezogabine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00188	0.0038	CcSEcCtD
Ezogabine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00188	0.0038	CcSEcCtD
Ezogabine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00188	0.00379	CcSEcCtD
Ezogabine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00188	0.00379	CcSEcCtD
Ezogabine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00188	0.00379	CcSEcCtD
Ezogabine—Mental disorder—Prednisone—ankylosing spondylitis	0.00187	0.00378	CcSEcCtD
Ezogabine—Malnutrition—Prednisone—ankylosing spondylitis	0.00186	0.00376	CcSEcCtD
Ezogabine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00186	0.00375	CcSEcCtD
Ezogabine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00185	0.00375	CcSEcCtD
Ezogabine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00181	0.00366	CcSEcCtD
Ezogabine—Anxiety—Betamethasone—ankylosing spondylitis	0.00181	0.00366	CcSEcCtD
Ezogabine—Discomfort—Dexamethasone—ankylosing spondylitis	0.0018	0.00363	CcSEcCtD
Ezogabine—Discomfort—Betamethasone—ankylosing spondylitis	0.0018	0.00363	CcSEcCtD
Ezogabine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00177	0.00356	CcSEcCtD
Ezogabine—Vision blurred—Prednisone—ankylosing spondylitis	0.00175	0.00354	CcSEcCtD
Ezogabine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00175	0.00354	CcSEcCtD
Ezogabine—Infection—Dexamethasone—ankylosing spondylitis	0.00173	0.0035	CcSEcCtD
Ezogabine—Infection—Betamethasone—ankylosing spondylitis	0.00173	0.0035	CcSEcCtD
Ezogabine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00173	0.00349	CcSEcCtD
Ezogabine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00173	0.00349	CcSEcCtD
Ezogabine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00172	0.00348	CcSEcCtD
Ezogabine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00172	0.00348	CcSEcCtD
Ezogabine—Visual impairment—Methotrexate—ankylosing spondylitis	0.00172	0.00348	CcSEcCtD
Ezogabine—Shock—Betamethasone—ankylosing spondylitis	0.00172	0.00347	CcSEcCtD
Ezogabine—Shock—Dexamethasone—ankylosing spondylitis	0.00172	0.00347	CcSEcCtD
Ezogabine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00171	0.00346	CcSEcCtD
Ezogabine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00171	0.00346	CcSEcCtD
Ezogabine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00171	0.00346	CcSEcCtD
Ezogabine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00171	0.00345	CcSEcCtD
Ezogabine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00171	0.00345	CcSEcCtD
Ezogabine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00169	0.00342	CcSEcCtD
Ezogabine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00169	0.00341	CcSEcCtD
Ezogabine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00169	0.00341	CcSEcCtD
Ezogabine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00169	0.00341	CcSEcCtD
Ezogabine—Malaise—Prednisone—ankylosing spondylitis	0.00168	0.00339	CcSEcCtD
Ezogabine—Vertigo—Prednisone—ankylosing spondylitis	0.00167	0.00338	CcSEcCtD
Ezogabine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00167	0.00337	CcSEcCtD
Ezogabine—Syncope—Prednisone—ankylosing spondylitis	0.00167	0.00337	CcSEcCtD
Ezogabine—Fatigue—Triamcinolone—ankylosing spondylitis	0.00166	0.00335	CcSEcCtD
Ezogabine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00165	0.00334	CcSEcCtD
Ezogabine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00164	0.0033	CcSEcCtD
Ezogabine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00158	0.0032	CcSEcCtD
Ezogabine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00158	0.00319	CcSEcCtD
Ezogabine—Anxiety—Prednisone—ankylosing spondylitis	0.00158	0.00319	CcSEcCtD
Ezogabine—Alopecia—Methotrexate—ankylosing spondylitis	0.00158	0.00319	CcSEcCtD
Ezogabine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00157	0.00316	CcSEcCtD
Ezogabine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00157	0.00316	CcSEcCtD
Ezogabine—Discomfort—Prednisone—ankylosing spondylitis	0.00157	0.00316	CcSEcCtD
Ezogabine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00157	0.00316	CcSEcCtD
Ezogabine—Malnutrition—Methotrexate—ankylosing spondylitis	0.00156	0.00314	CcSEcCtD
Ezogabine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00154	0.0031	CcSEcCtD
Ezogabine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00154	0.0031	CcSEcCtD
Ezogabine—Infection—Prednisone—ankylosing spondylitis	0.00151	0.00305	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00151	0.00304	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00151	0.00304	CcSEcCtD
Ezogabine—Fatigue—Dexamethasone—ankylosing spondylitis	0.0015	0.00304	CcSEcCtD
Ezogabine—Fatigue—Betamethasone—ankylosing spondylitis	0.0015	0.00304	CcSEcCtD
Ezogabine—Shock—Prednisone—ankylosing spondylitis	0.00149	0.00302	CcSEcCtD
Ezogabine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00149	0.00301	CcSEcCtD
Ezogabine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00147	0.00297	CcSEcCtD
Ezogabine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00147	0.00296	CcSEcCtD
Ezogabine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00144	0.00292	CcSEcCtD
Ezogabine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00144	0.0029	CcSEcCtD
Ezogabine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00144	0.0029	CcSEcCtD
Ezogabine—Malaise—Methotrexate—ankylosing spondylitis	0.0014	0.00283	CcSEcCtD
Ezogabine—Vertigo—Methotrexate—ankylosing spondylitis	0.0014	0.00282	CcSEcCtD
Ezogabine—Leukopenia—Methotrexate—ankylosing spondylitis	0.00139	0.00281	CcSEcCtD
Ezogabine—Dizziness—Prednisolone—ankylosing spondylitis	0.00138	0.00279	CcSEcCtD
Ezogabine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00138	0.00279	CcSEcCtD
Ezogabine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00138	0.00278	CcSEcCtD
Ezogabine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00136	0.00276	CcSEcCtD
Ezogabine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00134	0.0027	CcSEcCtD
Ezogabine—Rash—Prednisolone—ankylosing spondylitis	0.00132	0.00266	CcSEcCtD
Ezogabine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00132	0.00266	CcSEcCtD
Ezogabine—Fatigue—Prednisone—ankylosing spondylitis	0.00131	0.00265	CcSEcCtD
Ezogabine—Discomfort—Methotrexate—ankylosing spondylitis	0.00131	0.00264	CcSEcCtD
Ezogabine—Constipation—Prednisone—ankylosing spondylitis	0.0013	0.00262	CcSEcCtD
Ezogabine—Confusional state—Methotrexate—ankylosing spondylitis	0.00128	0.00259	CcSEcCtD
Ezogabine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00127	0.00257	CcSEcCtD
Ezogabine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00127	0.00256	CcSEcCtD
Ezogabine—Infection—Methotrexate—ankylosing spondylitis	0.00126	0.00255	CcSEcCtD
Ezogabine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00125	0.00253	CcSEcCtD
Ezogabine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00125	0.00253	CcSEcCtD
Ezogabine—Asthenia—Betamethasone—ankylosing spondylitis	0.00125	0.00253	CcSEcCtD
Ezogabine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00125	0.00251	CcSEcCtD
Ezogabine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00124	0.00251	CcSEcCtD
Ezogabine—Nausea—Prednisolone—ankylosing spondylitis	0.00124	0.00251	CcSEcCtD
Ezogabine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00123	0.00248	CcSEcCtD
Ezogabine—Rash—Triamcinolone—ankylosing spondylitis	0.00121	0.00245	CcSEcCtD
Ezogabine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00121	0.00245	CcSEcCtD
Ezogabine—Rash—Methylprednisolone—ankylosing spondylitis	0.00121	0.00244	CcSEcCtD
Ezogabine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00121	0.00244	CcSEcCtD
Ezogabine—Dizziness—Betamethasone—ankylosing spondylitis	0.00115	0.00233	CcSEcCtD
Ezogabine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00115	0.00233	CcSEcCtD
Ezogabine—Nausea—Triamcinolone—ankylosing spondylitis	0.00114	0.00231	CcSEcCtD
Ezogabine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00114	0.0023	CcSEcCtD
Ezogabine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00114	0.0023	CcSEcCtD
Ezogabine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00113	0.00229	CcSEcCtD
Ezogabine—Somnolence—Methotrexate—ankylosing spondylitis	0.00113	0.00228	CcSEcCtD
Ezogabine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00112	0.00226	CcSEcCtD
Ezogabine—Rash—Dexamethasone—ankylosing spondylitis	0.0011	0.00222	CcSEcCtD
Ezogabine—Rash—Betamethasone—ankylosing spondylitis	0.0011	0.00222	CcSEcCtD
Ezogabine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0011	0.00222	CcSEcCtD
Ezogabine—Dermatitis—Betamethasone—ankylosing spondylitis	0.0011	0.00222	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.0011	0.00221	CcSEcCtD
Ezogabine—Fatigue—Methotrexate—ankylosing spondylitis	0.00109	0.00221	CcSEcCtD
Ezogabine—Asthenia—Prednisone—ankylosing spondylitis	0.00109	0.0022	CcSEcCtD
Ezogabine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00105	0.00211	CcSEcCtD
Ezogabine—Nausea—Betamethasone—ankylosing spondylitis	0.00104	0.00209	CcSEcCtD
Ezogabine—Nausea—Dexamethasone—ankylosing spondylitis	0.00104	0.00209	CcSEcCtD
Ezogabine—Dizziness—Prednisone—ankylosing spondylitis	0.001	0.00203	CcSEcCtD
Ezogabine—Rash—Prednisone—ankylosing spondylitis	0.000958	0.00193	CcSEcCtD
Ezogabine—Dermatitis—Prednisone—ankylosing spondylitis	0.000957	0.00193	CcSEcCtD
Ezogabine—Asthenia—Methotrexate—ankylosing spondylitis	0.000911	0.00184	CcSEcCtD
Ezogabine—Nausea—Prednisone—ankylosing spondylitis	0.000903	0.00182	CcSEcCtD
Ezogabine—Dizziness—Methotrexate—ankylosing spondylitis	0.00084	0.0017	CcSEcCtD
Ezogabine—Rash—Methotrexate—ankylosing spondylitis	0.000801	0.00162	CcSEcCtD
Ezogabine—Dermatitis—Methotrexate—ankylosing spondylitis	0.0008	0.00162	CcSEcCtD
Ezogabine—Nausea—Methotrexate—ankylosing spondylitis	0.000754	0.00152	CcSEcCtD
